Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 4;13(3):464-472.
doi: 10.1080/15548627.2016.1271514. Epub 2017 Jan 5.

Multistep regulation of TFEB by MTORC1

Silvia Vega-Rubin-de-Celis  1   2 , Samuel Peña-Llopis  1   2 , Meghan Konda  1   2 , James Brugarolas  1   2
Affiliations

Multistep regulation of TFEB by MTORC1

Silvia Vega-Rubin-de-Celis et al. Autophagy. .

Abstract

The master regulator of lysosome biogenesis, TFEB, is regulated by MTORC1 through phosphorylation at S211, and a S211A mutation increases nuclear localization. However, TFEBS211A localizes diffusely in both cytoplasm and nucleus and, as we show, retains regulation by MTORC1. Here, we report that endogenous TFEB is phosphorylated at S122 in an MTORC1-dependent manner, that S122 is phosphorylated in vitro by recombinant MTOR, and that S122 is important for TFEB regulation by MTORC1. Specifically, nuclear localization following MTORC1 inhibition is blocked by a S122D mutation (despite S211 dephosphorylation). Furthermore, such a mutation inhibits lysosomal biogenesis induced by Torin1. These data reveal a novel mechanism of TFEB regulation by MTORC1 essential for lysosomal biogenesis.

Keywords: Lysosomal biogenesis; MTOR; TFEB; YWHA; subcellular localization.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Torin1 enhances TFEBS211A nuclear localization. (A) Validation of the newly generated p-TFEB (S211) antibody. HeLa cells were transfected with the indicated MYC-tagged plasmids (WT, wild-type TFEB; S211A TFEB mutant or EV, empty vector), lysed, and treated or not with lambda phosphatase (“λ”) before MYC immunoprecipitation (IP) and western blot analysis. (B) p-TFEB (S211) analysis of Torin1-treated HeLa cells (250 nM). Endogenous TFEB was immunoprecipitated and analyzed by western blot. (C) HeLa cells transfected with the indicated MYC-tagged TFEB constructs were subjected to immunoprecipitation with YWHA or MYC antibodies and analyzed by western blot. Torin1 (250 nM) for 6 h. Where indicated, immunoprecipitates were treated with lambda phosphatase (λ). (D) Quantification of TFEB-GFP or TFEBS211A-GFP subcellular localization in HeLa cells transfected as indicated (C, exclusively cytoplasmic; C and N, cytoplasmic and nuclear; N, exclusively nuclear). Graph illustrates average (n = 2; ≥100 cells per experiment) ± SD. *, P < 0.05 for comparison between TFEB-WT and TFEBS211A for each of the fractions. (E) HeLa cells were transfected with the indicated plasmids and biochemical fractionation was performed after Torin1 treatment (250 nM for 3 h). (F) HeLa cells stably expressing TFEB-GFP (WT vs. S211A) were treated with vehicle (DMSO) or Torin1 (250 nM for 6 h) and analyzed by immunofluorescence (left panel, representative images; middle panel, schematic representation; right panel, quantification). Two-factor ANOVA was used to compare the global effect of the TFEBS211A mutation. ***, P < 0.001; ns, nonsignificant. Scale bar: 20 μm.
Figure 2.
Figure 2.
TFEB serine 122 is regulated by MTORC1. (A) Validation of the p-TFEB (S122) antibody. HeLa cells were transfected with the indicated MYC-tagged TFEB constructs followed by MYC-IP and western blot. λ, lambda-phosphatase treatment of immunoprecipitates. HeLa cells were treated with Torin1 (250 nM) (B), or starved for amino acids (C), serum (D), or glucose (E). (F, G) HeLa cells were transfected with active (RRAGBGTP/DGDP) or inactive (RRAGBGDP/DGTP) RRAG-GTPases and its effects on TFEB localization and phosphorylation were assessed. (H) MTOR in vitro kinase assay of epitope tag immunoprecipitates from cells transfected with empty vector (EV) vs. MYC-TFEB and incubated with or without recombinant MTOR. Scale bar: 10 μm.
Figure 3.
Figure 3.
Serine 122 regulation is essential for TFEB-mediated lysosome biogenesis. (A, B) Subcellular localization of transfected full-length-TFEB or S122D mutant in HeLa cells analyzed by confocal microscopy or biochemical subcellular fractionation in cells treated or not with Torin1 (250 nM, 3 h). Graph represents average ± SD (n = 6; ≥ 100 cells per experiment; *, P < 0.05). (C, D) HeLa cells depleted of TFEB were transfected with the indicated constructs and treated with Torin1 for 36 h. Cells were stained with LysoTracker Red (C) or an antibody against LAMP1 (D) and analyzed by FACS. Graphs indicate mean ± SE (n = 3). Asterisks illustrate statistically significant differences in LysoTracker Red or LAMP1 intensity. **, P < 0.01. (E) qPCR analysis of TFEB-target genes in HeLa cells depleted of TFEB and transfected with the indicated constructs (Torin1 250 nM, 36 h). ***, P < 0.001.
Figure 4.
Figure 4.
Serine 122 contributes to TFEB nuclear enrichment in the context of S211A mutation (A-C) Subcellular localization of transfected full-length-TFEB, S122A, S211A or S122A;S211A mutants in HeLa cells by biochemical fractionation (A) or confocal microscopy (B, C) following (or not) treatment with Torin1 (250 nM, 3 h). Graph represents average ± SD (n = 3; ≥ 100 cells per experiment; ***, P < 0.01). (D) YWHA protein immunoprecipitation from HeLa cells transfected with the indicated TFEB constructs. (E) Western blot for S211 phosphorylation of wild-type or mutant MYC-TFEB immunoprecipitated from transfected HeLa cells. (F) Proposed model for TFEB regulation by MTORC1. Scale bar: 20 μm.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Srigley JR, Delahunt B. Uncommon and recently described renal carcinomas. Mod Pathol 2009; 22(Suppl 2):S2-S23; PMID:19494850; http://dx.doi.org/10.1038/modpathol.2009.70 - DOI - PubMed
    1. Davis IJ, Hsi BL, Arroyo JD, Vargas SO, Yeh YA, Motyckova G, Valencia P, Perez-Atayde AR, Argani P, Ladanyi M, et al.. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci U S A 2003; 100:6051-6; PMID:12719541; http://dx.doi.org/10.1073/pnas.0931430100 - DOI - PMC - PubMed
    1. Kuiper RP, Schepens M, Thijssen J, van Asseldonk M, van den Berg E, Bridge J, Schuuring E, Schoenmakers EF, van Kessel AG. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Human Mol Genet 2003; 12:1661-9; PMID:12837690; http://dx.doi.org/10.1093/hmg/ddg178 - DOI - PubMed
    1. Steingrimsson E, Copeland NG, Jenkins NA. Melanocytes and the microphthalmia transcription factor network. Ann Rev Genet 2004; 38:365-411; PMID:15568981; http://dx.doi.org/10.1146/annurev.genet.38.072902.092717 - DOI - PubMed
    1. Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, Di Malta C, Donaudy F, Embrione V, Polishchuk RS, et al.. A gene network regulating lysosomal biogenesis and function. Science (New York, NY 2009; 325:473-7. - PubMed

Substances